The average one-year price target for Eli Lilly (SWX: LLY) has been revised to CHF 997.26 per share, marking a 24.41% increase from the previous estimate of CHF 801.57, dated November 16, 2025. This target reflects a range from CHF 702.47 to CHF 1,288.74, indicating a potential rise of 43.49% from the latest closing price of CHF 695.00 per share.
As of the latest quarter, there are 4,406 funds or institutions reporting positions in Eli Lilly, a decrease of 1,105 or 20.05%. The total shares owned by these institutions dropped by 7.15% to 792,122K shares. Notable stakeholders include Lilly Endowment with 91,897K shares (10.27% ownership), PNC Financial Services Group holding 51,333K shares (5.74%), and Capital Research Global Investors with 24,567K shares (2.75%), all of which adjusted their portfolio allocations accordingly over the last quarter.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
